The Prevalence Of Orgasmic Dysfunction Among Malaysian Women Receiving Antidepressant: A Comparison Between Escitalopram And Fluoxetine
- Author:
Rozita Hod
;
Duni Asmindar Ahmad
;
Ng Chong Guan
;
Hatta Sidi
- Publication Type:Journal Article
- Keywords:
Orgasmic dysfunction, Malaysian women, antidepressant treatment
- From:ASEAN Journal of Psychiatry
2011;12(1):1-11
- CountryMalaysia
- Language:English
-
Abstract:
Objective: To investigate the prevalence of Female Orgasmic Dysfunction (FOD) focusing on
the orgasm domain among female patients attending PPUKM Psychiatric clinic. To compare the
prevalence of orgasmic dysfunction between female patients on Escitalopram and on Fluoxetine
therapy. Methods: A validated questionnaire for sexual function was used to assess orgasmic
function. A total of 112 women aged between 24 and 57 participated in this study. The orgasmic
dysfunction was compared between patients on selective serotonin reuptake inhibitors (SSRIs)
fluoxetine and escitalopram. Results: The prevalence of female orgasmic dysfunction was 58.9%
(33/56) among patients treated with Fluoxetine and 41.1% (23/56) among patients treated with
Escitalopram. However, there was no statistically significant difference between these two
treatment groups (p=0.059). The odds to have FOD among patients on higher dose of
antidepressants was found to be higher compared to those patients who were on lower dose of
antidepressants (Odds ratio 5.32, p= 0.001). Conclusion: There was no significant difference of
Female Orgasmic Dysfunction between patients on Fluoxetine and Escitalopram
